Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM)
- DOI
- 10.1007/s12094-019-02245-1
- Published
- 2019-11-22
- Container
- Clinical and Translational Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12094-019-02245-1,
title = {Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM)},
author = {P. Saez-Carlin and A. García-Botella and L. I. Diez-Valladares and L. Ortega Medina and R. Méndez and J. C. M. González and I. Bernal and I. Serrano García and R. Avellana and A. J. Torres García},
year = {2019},
journal = {Clinical and Translational Oncology},
doi = {10.1007/s12094-019-02245-1},
url = {https://doi.org/10.1007/s12094-019-02245-1}
}RIS
TY - JOUR TI - Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM) AU - P. Saez-Carlin AU - A. García-Botella AU - L. I. Diez-Valladares AU - L. Ortega Medina AU - R. Méndez AU - J. C. M. González AU - I. Bernal AU - I. Serrano García AU - R. Avellana AU - A. J. Torres García PY - 2019 JO - Clinical and Translational Oncology DO - 10.1007/s12094-019-02245-1 UR - https://doi.org/10.1007/s12094-019-02245-1 ER -
APA
Saez-Carlin, P., García-Botella, A., Diez-Valladares, L. I., Medina, L. O., Méndez, R., González, J. C. M., Bernal, I., García, I. S., Avellana, R., & García, A. J. T. (2019). Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM). Clinical and Translational Oncology. https://doi.org/10.1007/s12094-019-02245-1
Source records
- crossref · retrieved 2026-09-26T07:27:58.046Z